鞘脂代谢及其相关疾病研究进展

近年对鞘脂代谢及其产物的研究越来越多.鞘脂及其代谢产物不仅是构成细胞膜的重要结构分子,而且参与调节细胞的生长、分化、衰老和细胞程序性死亡等许多重要的信号转导过程,使细胞产生各种不同的生物学功能.该文综述了鞘脂代谢途径的重要酶,鞘脂及其代谢产物的功能,以及它们与相关疾病的研究进展,并就其存在的问题和今后可能的研究方向做出展望.为鞘脂代谢的过程和鞘脂相关疾病的生理病理学研究提供重要的理论依据.     

非律平菌素干扰甲基硝基亚硝基胍对FL细胞鞘脂代谢的影响

甲基硝基亚硝基胍（MNNG）可通过脂筏诱导细胞表面受体聚簇并激活NF-κB信号通路.本研究拟探讨脂筏干扰剂非律平菌素（filipin）对MNNG作用的影响.利用脂类组学方法分别研究了MNNG、filipin 单独处理及先用filipin再用MNNG处理情况下对人羊膜FL细胞鞘脂代谢的影响,用MALDI-TOF质谱法分析细胞鞘脂组成的变化,酶联免疫吸附法检测NF-κB通路的活化,RT-PCR法检测鞘脂代谢通路中关键酶的表达.结果表明,MNNG和filipin都可影响FL细胞鞘脂类代谢,但MNNG作用更显著.Filipin预处理可部分抑制MNNG对细胞鞘脂类代谢的影响,且能够抑制MNNG对NF-κB的活化;但filipin、MNNG单独或联合处理都不影响鞘脂代谢关键酶丝氨酸棕榈酰转移酶、酸性鞘磷脂酶和鞘磷脂合成酶在mRNA水平的表达.以上结果说明,filipin预处理会导致甲基硝基亚硝基胍引起FL细胞鞘脂代谢以及NF-κB活性的改变.而可能的机制在于,filipin破坏脂筏结构从而引起一系列信号途径的改变,而非通过改变脂类代谢关键酶的表达.     

鞘脂类的研究进展

鞘脂类研究是目前脂类研究的重点之一,鞘脂类研究进展有以下几方面:首先,鞘脂类具有结构上的多样性,可能的种类数量巨大;其次,人们已经克隆了大多数在鞘脂代谢途径中具有调控作用的酶类,研究的热点正在转向其调节机制;再次鞘脂类合成发生在内质网和高尔基体,通过协助扩散进行转运,CERT帮助神经酰胺从内质网到高尔基体的转运;第四,鞘脂类在细胞信号转导中起重要作用,神经酰胺和SIP是当前集中的研究对象;第五,鞘脂在脂筏的形成中具有重要作用,其特异性分布可能与脂筏的功能相关.鞘脂类的研究正在系统化,"(鞘)脂类组学"的提出有助于研究的进一步深入.     

真菌鞘糖脂的生物学功能及应用研究进展

丝状真菌作为一类重要的微生物，被广泛应用于发酵食品、工业酶和次生代谢物等工业生产中。真菌鞘糖脂主要由鞘氨醇、脂肪酸链和特殊的极性基团组成，根据极性基团的不同，分为中性鞘糖脂和酸性鞘糖脂两大类。鞘糖脂不仅参与真菌生长、细胞分化、增殖、细胞凋亡、逆境胁迫等重要生理活动，中性鞘糖脂还可作为功能性医药用品、化妆品和保健食品的重要活性组分。本文论述了真菌鞘糖脂的主要种类、结构、生物合成途径和及其参与丝状真菌生长、分化和响应逆境胁迫的生物学功能；探讨了真菌中性鞘糖脂作为抗菌肽的靶点和酸性鞘糖脂在开发抗真菌药物中的应用；同时还综述了中性鞘糖脂作为化妆品的保湿成分或保健食品的功能成分，在改善皮肤屏障功能和预防特应性皮炎中的重要作用的相关研究进展，尤其是来源于曲霉的中性鞘糖脂，可显著增强皮肤屏障功能，并可作为益生元预防肠道损伤；另外还探讨了曲霉尤其是米曲霉作为开发中性鞘糖脂生物资源的优势。     

鞘脂在植物-真菌互作中的分子调控机制研究进展

鞘脂是细胞生物膜结构的重要组分, 鞘脂及其代谢产物参与许多重要的信号转导过程。在植物-真菌互作中, 植物鞘脂的主要作用是诱导细胞发生程序性死亡; 真菌鞘脂既能引起植物死亡, 也能诱导植物产生抗病性。该文总结了植物和真菌鞘脂的结构及代谢特点, 综述了鞘脂参与调控植物-真菌互作的分子机制研究进展, 并展望了植物-真菌共生关系中鞘脂作用的研究方向。     

鞘脂在植物-真菌互作中的分子调控机制研究进展

鞘脂是细胞生物膜结构的重要组分, 鞘脂及其代谢产物参与许多重要的信号转导过程。在植物-真菌互作中, 植物鞘脂的主要作用是诱导细胞发生程序性死亡; 真菌鞘脂既能引起植物死亡, 也能诱导植物产生抗病性。该文总结了植物和真菌鞘脂的结构及代谢特点, 综述了鞘脂参与调控植物-真菌互作的分子机制研究进展, 并展望了植物-真菌共生关系中鞘脂作用的研究方向。     

鞘脂代谢关键酶丝氨酸棕榈酰转移酶的结构、功能及其相关疾病

鞘脂(sphingolipids)是生物细胞中最主要的膜脂之一，同时也作为信号分子介导细胞生长、增殖、迁移及死亡等重要的生理反应，异常鞘脂代谢经常与心血管疾病、糖尿病、癌症、神经变性病以及自身免疫性疾病等相关。丝氨酸棕榈酰转移酶(serine palmitoyltransferase, SPT)及其复合物是鞘脂从头合成途径的起始酶和关键酶，催化L-丝氨酸与棕榈酰辅酶A缩合形成3-酮二氢鞘氨醇，之后再经过一系列反应生成神经酰胺和其它重要的鞘脂，在鞘脂代谢和稳态调节方面发挥重要作用。本文基于国内外对SPT的研究，综述了SPT的构型、活性位点、底物结合位点等关键的结构信息，尤其近2年的研究发现，SPT是一种组成极其复杂的酶，各个亚基之间存在错综复杂的相互作用和高度调控。SPT具有重要的生物学功能，包括参与胚胎发育、调节内环境稳态、诱导细胞凋亡和参与机体免疫调节等。SPT还可以通过调节酶活性影响鞘脂代谢，进而影响血管疾病和肿瘤的发生发展，并有潜力成为肿瘤诊断和治疗的关键分子。此外，SPT突变体与神经变性病密切相关，本文着重介绍了遗传性感觉与自主神经病变1型(hereditary sensory...     

真菌草酸的代谢和作用研究进展

草酸(oxalic acid)是一种重要的生物代谢产物,广泛分布于植物、动物和微生物中,在不同的生命体中发挥重要功能.本文回顾了国内外关于真菌草酸的相关研究进展.许多真菌能够分泌草酸,包括植物病原真菌、食药用真菌及工业真菌等.草酸作为一种简单的二元羧酸,在真菌中主要通过三羧酸循环途径、乙醛酸循环途径和草酰乙酸途径合成....     

鞘磷脂代谢与脑缺血

鞘磷脂特别是鞘脂是髓鞘的主要成分,高度集中在中枢神经系统。在生理和病理生理条件下,具有生物活性的鞘磷脂及其代谢产物以及信号传导过程的重要性正在逐步被人们所认识。鞘脂代谢产物鞘氨醇及其前体物质神经酰胺与细胞生长停滞和凋亡有关,而1-磷酸鞘氨醇与增强细胞增殖、分化和细胞生存以及调节细胞的生理和病理过程有关,具有细胞外第一信使和细胞内第二信使的双重功能。这三者之间的相互转换、鞘脂代谢物的相对水平以及细胞的命运,受到鞘氨醇激酶的活性的强烈影响。鞘氨醇激酶可催化磷酸鞘氨醇产生1-磷酸鞘氨醇。1-磷酸鞘氨醇在中枢神经系统中与G蛋白偶联受体家族结合对中枢神经系统发挥作用。本文对鞘磷脂代谢过程中的鞘氨醇激酶、1-磷酸鞘氨醇及其受体与脑缺血之间的关系进行概述。     

鞘氨醇-1-磷酸与免疫细胞的调节

鞘氨醇-1-磷酸（sphingosine-1 phosphate,S1P）是来源于鞘脂代谢途径的多效性信号分子,其代谢受到多种因素调控。S1P由细胞内的鞘氨醇激酶（sphingosine kinases,SphKs）催化鞘氨醇的磷酸化而合成,可通过转运蛋白释放至细胞外。S1P可通过在胞外结合其特异性G蛋白偶联受体及胞内作用而调节多种重要生物学效应。作为细胞外介质和细胞内信使,S1P在免疫系统中也发挥重要的调节作用。S1P参与免疫细胞的迁移、增殖、分化及死亡细胞清除等过程。本文对S1P的代谢以及其对于免疫细胞的调节作用进行综述。     

Fumonisins: fungal toxins that shed light on sphingolipid function

Fumonisins are sphinganine analogues produced by Fusarium moniliforme and related fungi. They inhibit ceramide synthase and block the biosynthesis o f complex sphingolipids, promoting accumulation o f sphinganine and sphinganine 1 phosphate. Disruption o f sphingolipid metabolism by fumonisin B(1) alters cell-cell interactions, the behaviour o f cell-surface proteins, the activity o f protein kinases, the metabolism of other lipids, and cell growth and viability. This multitude of effects probably accounts for the toxicity and carcinogenicity of these mycotoxins. Naturally occurring inhibitors o f sphingolipid metabolism such as fumonisins are proving to be powerful tools for studying the diverse roles of sphingolipids in cell regulation and disease.     

Yeast sphingolipids: metabolism and biology

Sphingolipids have recently emerged as important bioactive molecules in addition to being critical structural components of cellular membranes. These molecules have been implicated in regulating cell growth, differentiation, angiogenesis, apoptosis, and senescene. To study sphingolipid mediated biology, it is necessary to investigate sphingolipid metabolism and its regulation. The yeast Saccharomyces cerevisiae has allowed such studies to take place as the sphingolipid metabolic and regulatory pathways appear conserved across species. Using yeast genetic approaches most enzymes of sphingolipid metabolism have been identified and cloned which has led to identification of their mammalian homologues. Many of the yeast enzymes are targets of fungal toxins thus underscoring the importance of this pathway in yeast cell regulation. This review focuses on the yeast sphingolipid metabolic pathway and its role in regulation of yeast biology. Implication of the insights gained from yeast to mammalian cell regulation are discussed.     

A Novel Jaspine BCeramide Hybrid Modulates Sphingolipid Metabolism

A new sphingolipid hybrid molecule was designed to assemble, within a tail‐to‐tail double‐chain structure, the ceramide hydrophilic moiety and the tetrahydrofuran pharmacophore of jaspine B, a natural product known to interfere with sphingolipid metabolism. This compound was prepared through acylation of sphingosine with a jaspine B derivative bearing a COOH group in the terminal position of the aliphatic backbone. This new hybrid molecule was evaluated for its capacities to affect melanoma cell viability and sphingolipid metabolism. While retaining the cytotoxicity of ceramide itself, this compound was shown to lower the sphingomyelin cellular levels and significantly enhance the production of sphingosine‐1‐phosphate, thus representing a novel sphingolipid metabolism modulator.     

Molecular facets of sphingolipids: Mediators of diseases

Sphingolipids constitute a biologically active lipid class that is significantly important from both structural and regulatory aspects. The manipulation of sphingolipid metabolism is currently being studied as a novel strategy for cancer therapy. The basics of this therapeutic approach lie in the regulation property of sphingolipids on cellular processes, which are important in a cell's fate, such as cell proliferation, apoptosis, cell cycle arrest, senescence, and inflammation. Furthermore, the mutations in the enzymes catalyzing some specific reactions in the sphingolipid metabolism cause mortal lysosomal storage diseases like Fabry, Gaucher, Niemann-Pick, Farber, Krabbe, and Metachromatic Leukodystrophy. Therefore, the alteration of the sphingolipid metabolic pathway determines the choice between life and death. Understanding the sphingolipid metabolism and regulation is significant for the development of new therapeutic approaches for all sphingolipid-related diseases, as well as for cancer. An important feature of the sphingolipid metabolic pathway is the compartmentalization into endoplasmic reticulum, the Golgi apparatus, lysosome and plasma membrane, and this compartmentalization makes the transport of sphingolipids critical for proper functioning. This paper focuses on the structures, metabolic pathways, localization, transport mechanisms, and diseases of sphingolipids in Saccharomyces cerevisiae and humans, and provides the latest comprehensive information on sphingolipid research.     

Jasmonates modulate sphingolipid metabolism and accelerate cell death in the ceramide kinase mutant acd5

Sphingolipids are structural components of the lipid bilayer that acts as signaling molecules in many cellular processes, including cell death. Ceramides, key intermediates in sphingolipid metabolism, are phosphorylated by the ceramide kinase ACCELERATED CELL DEATH5 (ACD5). The loss of ACD5 function leads to ceramide accumulation and spontaneous cell death. Here, we report that the jasmonate (JA) pathway is activated in the Arabidopsis (Arabidopsis thaliana) acd5 mutant and that methyl JA treatment accelerates ceramide accumulation and cell death in acd5. Moreover, the double mutants of acd5 with jasmonate resistant1-1 and coronatine insensitive1-2 exhibited delayed cell death, suggesting that the JA pathway is involved in acd5-mediated cell death. Quantitative sphingolipid profiling of plants treated with methyl JA indicated that JAs influence sphingolipid metabolism by increasing the levels of ceramides and hydroxyceramides, but this pathway is dramatically attenuated by mutations affecting JA pathway proteins. Furthermore, we showed that JAs regulate the expression of genes encoding enzymes in ceramide metabolism. Together, our findings show that JAs accelerate cell death in acd5 mutants, possibly by modulating sphingolipid metabolism and increasing ceramide levels.     

Enzymes of sphingolipid metabolism: from modular to integrative signaling

Many enzymes of sphingolipid metabolism are regulated in response to extra- and intracellular stimuli and in turn serve as regulators of levels of bioactive lipids (such as sphingosine, ceramide, sphingosine 1-phosphate, and diacylglycerol), and as such, they serve a prototypical modular function in cell regulation. However, lipid metabolism is also closely interconnected in that a product of one enzyme serves as a substrate for another. Moreover, many cell stimuli regulate more than one of these enzymes, thus adding to the complexity of regulation of lipid metabolism. In this paper, we review the status of enzymes of sphingolipid metabolism in cell regulation and propose a role for these enzymes in integration of cell responses, a role that builds on the modular organization while also taking advantage of the complexity and interconnectedness of lipid metabolism, thus providing for a combinatorial mechanism of generating diversity in cell responses. This may be a general prototype for the involvement of metabolic pathways in cell regulation.     

Sphingolipids as modulators of cancer cell death: Potential therapeutic targets

Through modifications in the fine membrane structure, cell-cell or cell-matrix interactions, and/or modulation of intracellular signaling pathways, sphingolipids can affect the tumorigenic potential of numerous cell types. Whereas ceramide and its metabolites have been described as regulators of cell growth and apoptosis, these lipids as well as other sphingolipid molecules can modulate the ability of malignant cells to grow and resist anticancer treatments, and their susceptibility to non-apoptotic cell deaths. This review summarizes our current knowledge on the properties of sphingolipids in the regulation of cancer cell death and tumor development. It also provides an update on the potential perspectives of manipulating sphingolipid metabolism and using sphingolipid analogues in anticancer therapy.     

Sphingolipids as modulators of cancer cell death: potential therapeutic targets

Through modifications in the fine membrane structure, cell-cell or cell-matrix interactions, and/or modulation of intracellular signaling pathways, sphingolipids can affect the tumorigenic potential of numerous cell types. Whereas ceramide and its metabolites have been described as regulators of cell growth and apoptosis, these lipids as well as other sphingolipid molecules can modulate the ability of malignant cells to grow and resist anticancer treatments, and their susceptibility to non-apoptotic cell deaths. This review summarizes our current knowledge on the properties of sphingolipids in the regulation of cancer cell death and tumor development. It also provides an update on the potential perspectives of manipulating sphingolipid metabolism and using sphingolipid analogues in anticancer therapy.     

Functions and metabolism of sphingolipids in Saccharomyces cerevisiae

We describe recent advances in understanding sphingolipid functions and metabolism in the baker’s yeast Saccharomyces cerevisiae. One milestone has been reached in yeast sphingolipid research with the complete or nearly complete identification of genes involved in sphingolipid synthesis and breakdown. Other advances include roles for sphingolipid long-chain bases as signaling molecules that regulate growth, responses to heat stress, cell wall synthesis and repair, endocytosis and dynamics of the actin cytoskeleton. We touch briefly on other sphingolipid functions so that readers unfamiliar with the field will gain a broader view of sphingolipid research. These functions include roles in protein trafficking/exocytosis, lipid rafts or microdomains, calcium homeostasis, longevity and cellular aging, nutrient uptake, cross-talk with other lipids and the interaction of sphingolipids and antifungal drugs.     

S1P-lyase deficiency uncouples ganglioside formation – Potential contribution to tumorigenic capacity

Sphingosine-1-phosphate (S1P) is not only a catabolic intermediate of all sphingolipids but also an evolutionary conserved bioactive lipid with critical functions in cell survival, differentiation, and migration as well as in immunity and angiogenesis. S1P-lyase (SGPL1) irreversibly cleaves S1P in the final step of sphingolipid catabolism. As sphingoid bases and their 1-phosphates are not only metabolic intermediates but also highly bioactive lipids that modulate a wide range of physiological processes, it would be predicted that their elevation might induce adjustments in other facets of sphingolipid metabolism and/or alter cell behavior. We actually found in a previous study that in terminally differentiated neurons SGPL1 deficiency increases sphingolipid formation via recycling at the expense of de novo synthesis. We now investigated whether and how SGPL1 deficiency affects the metabolism of (glyco)sphingolipids in mouse embryonic fibroblasts (MEFs). According to our previous experiments in neurons, we found a strong accumulation of S1P in SGPL1-deficient MEFs. Surprisingly, a completely different situation arose as we analyzed sphingolipid metabolism in this non-differentiated cell type. The production of biosynthetic precursors of complex glycosphingolipids including ceramide, glucosylceramide and also ganglioside GM3 via de novo synthesis and recycling pathway was substantially increased whereas the amount of more complex gangliosides dropped significantly.